BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 2880828)

  • 1. [Immunologic phenotyping of cutaneous lymphomas].
    Kaudewitz P; Burg G; Smolle J; Braun-Falco O
    Hautarzt; 1986 Dec; 37(12):647-55. PubMed ID: 2880828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunological characterization of malignant epidermotropic lymphoma cells in cutaneous infiltrates (author's transl)].
    Thivolet J; Souteyrand P; Alario A; Schmitt D; Perrot H
    Dermatologica; 1978; 157(6):357-64. PubMed ID: 363474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells.
    Haynes BF; Metzgar RS; Minna JD; Bunn PA
    N Engl J Med; 1981 May; 304(22):1319-23. PubMed ID: 6971410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-7 receptor expression in cutaneous T-cell lymphomas.
    Bagot M; Charue D; Boulland ML; Gaulard P; Revuz J; Schmitt C; Wechsler J
    Br J Dermatol; 1996 Oct; 135(4):572-5. PubMed ID: 8915148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T-cell leukemia virus in cutaneous T-cell lymphoma in Denmark. A possible association of HTLV and aneuploidy.
    Lange Wantzin G; Saxinger WC; Woods A; Larsen JK; Thomsen K; Gallo RC
    Acta Derm Venereol; 1984; 64(5):395-9. PubMed ID: 6208717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotype of cells involved in mycosis fungoides and Sézary syndrome (blood and skin lesions): immunomorphological study with monoclonal antibodies.
    Schmitt D; Souteyrand P; Brochier J; Czernielewski J; Thivolet J
    Acta Derm Venereol; 1982; 62(3):193-9. PubMed ID: 6179357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human T-cell leukemia (lymphoma) virus (HTLV-I) antibodies in Danish patients with cutaneous T-cell lymphoma].
    Wantzin GL
    Hautarzt; 1986 May; 37(5):263-5. PubMed ID: 3015842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathology of cutaneous T-cell lymphomas.
    Nasu K; Said J; Vonderheid E; Olerud J; Sako D; Kadin M
    Am J Pathol; 1985 Jun; 119(3):436-47. PubMed ID: 3893149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sézary syndrome. Clinical, immunological and proliferative kinetics].
    Marosi L; Hofer F; Schwarzmeier J; Konrad K; Knapp W; Radaskiewicz T
    Acta Med Austriaca; 1979; 6(5):237-40. PubMed ID: 318012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cells in the epidermotropic lymphomas (mycosis fungoides and Sézary syndrome. Study using monoclonal antibodies].
    Thivolet J; Schmitt D; Souteyrand P; Brochier J
    Nouv Presse Med; 1982 Oct; 11(41):3033-8. PubMed ID: 6755391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the cutaneous T cell lymphomas.
    Edelson RL
    Bull Cancer; 1977; 64(2):209-24. PubMed ID: 303131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous T cell lymphomas: mycosis fungoides, Sézary syndrome and lymphomatoid papulosis--part II.
    Safai B
    Clin Bull; 1977; 7(4):140-5. PubMed ID: 147147
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides.
    Ralfkiaer E; Saati TA; Bosq J; Delsol G; Gatter KC; Mason DY
    J Clin Pathol; 1986 May; 39(5):553-63. PubMed ID: 3522633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
    Magro CM; Dyrsen ME
    J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody patterns in cutaneous lymphoid infiltrates. Their possible relevance to the diagnosis and categorization of cutaneous lymphomas.
    McMillan EM
    Dermatol Clin; 1985 Oct; 3(4):593-603. PubMed ID: 2947768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and hematological heterogeneity of T-cell derived lymphoproliferative diseases.
    Brouet JC; Flandrin G
    Bull Cancer; 1977; 64(2):267-74. PubMed ID: 143976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
    Schmitt D; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surface marker studies on lymphoma and leukemia cells with microcytotoxicity test using the UCLA Monoclonal Antibody Tray 5].
    Toki H; Okabe K; Kimura Y; Fujii M; Tamai M; Moriwaki S; Yamamoto Y
    Gan No Rinsho; 1985 Apr; 31(4):409-13. PubMed ID: 3874297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunocytological study of cutaneous malignant lymphomas. Classification (author's transl)].
    Souteyrand P; Thivolet J; Alario A; Schmitt D; Perrot H
    Dermatologica; 1978; 157(5):268-81. PubMed ID: 150348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.